Class Cert. Denied Again In Gout Drug Antitrust Case
A Pennsylvania federal court has again refused to certify a class of drug wholesalers accusing Takeda Pharmaceuticals and others of delaying generic competition for the anti-gout drug Colcrys, finding that it...To view the full article, register now.
Already a subscriber? Click here to view full article